Lead & Executive Director, Merck for Mothers
Dr. Mary-Ann Etiebet has two decades of experience improving healthcare outcomes for vulnerable populations and transforming healthcare delivery at the frontlines. She is the Lead & Executive Director of Merck for Mothers, Merck’s $500M global health initiative to help create a world where no woman has to die while giving life. Between 2011 and 2019, Merck for Mothers maternal health programs and partnerships have resulted in healthy pregnancies and safe deliveries for over 10M women in 48 countries.
Mary-Ann draws on extensive experience in the private, public and not-for-profit sectors for this role. She joins Merck for Mothers from Premier Inc, where she was a Principal Consultant in the Population Health Management team. Previously, she served as Director of Ambulatory Care Strategies for New York City Health and Hospital. Her work in global health includes serving as the Senior Technical Advisor of the Institute of Human Virology-Nigeria, a PEPFAR implementing partner, while she was Assistant Professor, Division of Infectious Disease at the University of Maryland School of Medicine.
Mary-Ann earned her MD and MBA from Yale University. She completed her residency in Internal Medicine at New York-Presbyterian Weill Cornell and fellowship in Infectious Diseases Hospital System at New York-Presbyterian Columbia University Medical Center, becoming Board Certified in both Internal Medicine and Infectious Diseases. She serves as a member of the Center for Global Development (CGD) Board of Directors; the UCSF Institute Health Sciences Global Health Group Advisory Board; the Partnership for Maternal, Newborn & Child Health Board; the Investors Group of the World Bank’s Global Financing Facility; the Maternal Morbidity and Mortality Committee of the National Quality Forum; and the Johns Hopkins Leadership Fellows program.